COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
doi: https://doi.org/10.1101/2021.03.04.21252540
University of Toronto
Prabhat Jha
University of Toronto
Article usage
Posted March 05, 2021.
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
medRxiv 2021.03.04.21252540; doi: https://doi.org/10.1101/2021.03.04.21252540
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (633)
- Anesthesia (168)
- Cardiovascular Medicine (2408)
- Dermatology (208)
- Emergency Medicine (382)
- Epidemiology (11811)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3778)
- Geriatric Medicine (350)
- Health Economics (637)
- Health Informatics (2413)
- Health Policy (941)
- Hematology (343)
- HIV/AIDS (789)
- Medical Education (370)
- Medical Ethics (105)
- Nephrology (402)
- Neurology (3533)
- Nursing (199)
- Nutrition (530)
- Oncology (1836)
- Ophthalmology (541)
- Orthopedics (222)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (67)
- Pathology (448)
- Pediatrics (1040)
- Primary Care Research (424)
- Public and Global Health (6192)
- Radiology and Imaging (1295)
- Respiratory Medicine (833)
- Rheumatology (380)
- Sports Medicine (324)
- Surgery (407)
- Toxicology (51)
- Transplantation (173)
- Urology (148)